Revvity is trading at $169.94, up 12.10%, after third-quarter adjusted EPS and revenue both exceeded expectations.

  • Adjusted EPS was $1.38 and revenue was $728.9 million; pro forma organic growth reached 7%.
  • Management raised 2026 pro forma adjusted EPS guidance to $5.40–$5.45 and expects about 5% organic growth.
  • The move is company-specific; the broader market was mixed, with no matching market-wide rally.